Merete Toemobile Anatomical Great Toe Resurfacing System
Merete Medical
FDA Clearance Information
The Merete Toemobile Anatomical Great Toe Resurfacing System was cleared through the FDA 510(k) pathway on May 8, 2008. It is manufactured by Merete Medical and does not have a specific device classification.
What It Is
FDA-Cleared Indications
- Resurfacing of the great toe metatarsophalangeal joint in patients with degenerative joint disease.
- Resurfacing of the great toe metatarsophalangeal joint in patients with deformity.
Clinical Applications
- Great toe joint resurfacing during orthopedic surgery.
- Treatment of degenerative disease affecting the great toe metatarsophalangeal joint.
- Treatment of a painful or function-limiting great toe joint deformity when joint resurfacing is selected.
- Use in adult patients with degenerative or deforming conditions of the great toe joint, based on clinical evaluation and product labeling.
Practical Considerations
- The surgeon should select component sizes and positioning based on the patient's anatomy and the manufacturer’s surgical technique.
- Confirm that the available instruments and implant components are compatible before surgery.
- Patient selection should account for bone quality, deformity, infection risk, activity level and other factors that can affect implant fixation or joint function.
- MRI safety and artifact information should be confirmed in the current manufacturer’s instructions for use; this record does not establish that the implant is MR Safe or MR Conditional.
- The device should be used only by appropriately trained clinicians and according to the current labeling. Contraindications and warnings should be reviewed before implantation.
Frequently Asked Questions
What is the Merete Toemobile Anatomical Great Toe Resurfacing System used for?
It is used for resurfacing the great toe joint to treat degenerative joint diseases and deformities.
What specialties typically use this device?
Orthopedic surgeons typically use this device in procedures related to the great toe joint.
What are the FDA-cleared indications?
The device is indicated for patients with degenerative joint disease or deformities of the great toe, aiming to restore function and alleviate pain.